Perrigo | PRGO - هزینه بهره بدهی





هزینه بهره بدهی تغییر دادن تاریخ
AbbVie USD 740M 40M 2025-06
Abbott USD 42M 2M 2025-12
Bayer EUR 675M 87M 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Coherus Biosciences USD 2.25M 76K 2025-12
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Dr.Reddys Laboratories INR 944M 37M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
J&J USD 18M 290M 2025-09
Merck USD 412M 85M 2025-12
Nestle CHF 897M 32M 2025-12
Pacira USD 3.89M 387K 2025-12
Perrigo USD 10.08B 10.04B 2025-09
Pfizer USD 711M 59M 2025-12
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Reckitt Benckiser GBP 208M 198.3M 2024-12
Sanofi EUR -25M 252M 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
Teva Pharmaceutical Industries USD 220M 17M 2025-12
Xeris Pharmaceuticals USD 7.15M 115K 2025-12
Zoetis USD 57M 1000K 2025-12